Study identifies NCOA3 as a novel therapeutic target for melanoma

[News]

For the first time, activation of nuclear receptor coactivator 3 (NCOA3) has been shown to promote the development of melanoma through regulation of ultraviolet radiation (UVR) sensitivity, cell cycle progression and circumvention of the DNA damage response.

More... (https://www.news-medical.net/news/20210325/Study-identifies-NCOA3-as-a-novel-therapeutic-target-for-melanoma.aspx)